Seventy‐two weeks of peginterferon and ribavirin for patients with partial early virologic response?
John C. Hoefs, Timothy R. Morgan – 28 November 2007
John C. Hoefs, Timothy R. Morgan – 28 November 2007
Ragai R. Mitry, Ruth De Bruyne, Alberto Quaglia, Robin D. Hughes, Anil Dhawan – 28 November 2007
Jennifer T. Wells, Adnan Said, Rashmi Agni, Santiago Tome, Sarah Hughes, Parul Dureja, Michael R. Lucey – 28 November 2007 – Patients with clinical acute alcoholic hepatitis (AAH) are not considered suitable candidates for orthotopic liver transplantation (OLT). The histological correlates of AAH are often seen in the explanted liver at the time of transplantation. The importance of these findings remains inconclusive regarding their role as a prognostic marker for patient or allograft health.
Nicholas A Shackel, Fiona J Warner – 28 November 2007
28 November 2007
Paul J. Gow, Stephen Warrilow, Steve Lontos, John Lubel, Sarah Wongseelashote, Gerry C. MacQuillan, Robert M. Jones, Rinaldo Bellomo, Peter W. Angus – 28 November 2007
Supha K. Arthurs, Albert J. Eid, Rachel A. Pedersen, Ross A. Dierkhising, Walter K. Kremers, Robin Patel, Raymund R. Razonable – 28 November 2007 – Clinical practice guidelines recommend antiviral prophylaxis to cytomegalovirus (CMV) donor‐positive/recipient‐negative (D+/R−) liver transplant recipients. We assessed the outcome of this strategy by determining the incidence, clinical features, and risk factors of CMV disease among CMV D+/R− liver transplant recipients who received antiviral prophylaxis.
Ileana Lopez‐Plaza – 28 November 2007
Paul J. Thuluvath – 28 November 2007
Prachi S. Patil, Mohandas K. Mallath – 28 November 2007